查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386123

狗疫苗市场报告：2030 年趋势、预测和竞争分析

Dog Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

狗狗疫苗的趋势和预测

预计到 2030 年，全球狗疫苗市场将达到 46 亿美元，2024 年至 2030 年复合年增长率为 5.7%。这个市场的主要驱动力是宠物狗数量的增加、狗饲主对狗的预防保健意识的提高以及政府有关疫苗接种的法规。全球狗疫苗市场前景广阔，兽医院/诊所市场和宠物主人市场蕴藏商机。

狗疫苗市场洞察

Lucintel 预测，由于犬类感染疾病的增加以及与其他疫苗相比更方便、更有效的事实，减毒活活病毒疫苗仍将是最大的细分市场。

在这个市场中，预计兽医院和诊所将在预测期内实现高速成长。

由于政府对疫苗接种的严格规定，北美将继续成为最大的地区，以保护狗免受严重疾病的侵害，同时保护生命免受狗咬伤。

市场规模/估计：狗疫苗的市场规模以金额估计（10 亿美元）。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

細項分析：按类型、年龄、最终用途、地区和金额（十亿美元）分析犬疫苗市场规模。

区域分析：北美、欧洲、亚太地区和世界其他地区狗疫苗市场的区域细分。

成长机会：依犬疫苗类型、年龄、最终用途和地区进行成长机会分析。

策略分析：狗疫苗市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球狗狗疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球狗疫苗市场趋势（2018-2023）和预测（2024-2030）
  • 全球狗疫苗市场（按类型）
    • 减毒活病毒疫苗
    • 结合疫苗
    • 灭活疫苗
    • 次单位疫苗
    • 类毒素疫苗
    • DNA疫苗
    • 重组疫苗
  • 按年龄分類的全球狗疫苗市场
    • 少于6个月
    • 6个月或以上
  • 全球狗疫苗市场（按最终用途）
    • 兽医医院和诊所
    • 宠物饲主
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球狗疫苗市场区域分布
  • 北美狗疫苗市场
  • 欧洲狗疫苗市场
  • 亚太地区狗疫苗市场
  • 其他地区狗疫苗市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球狗疫苗市场成长机会
    • 按年龄分類的全球狗疫苗市场成长机会
    • 全球狗疫苗市场成长机会（按最终用途）
    • 全球狗疫苗市场成长机会（按地区）
  • 全球狗疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球狗疫苗市场产能扩张
    • 全球狗疫苗市场的併购、收购和合资合併
    • 认证和许可

第七章主要企业概况

  • Bayer
  • Vetquinol
  • Boehringer Ingelhiem
  • Ceva
  • Eli Lilly
  • Heska
  • Merck
简介目录

Dog Vaccine Trends and Forecast

The future of the global dog vaccine market looks promising with opportunities in the veterinary hospital & clinic and pet owner markets. The global dog vaccine market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are increasing adoption of pet dogs, pet owners are becoming more aware of the benefits of preventive healthcare for their dogs, and government regulations for vaccinations.

A more than 150-page report is developed to help in your business decisions.

Dog Vaccine by Segment

The study includes a forecast for the global dog vaccine by type, age, end use, and region.

Dog Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccine

Dog Vaccine Market by Age [Shipment Analysis by Value from 2018 to 2030]:

  • Below 6 Months
  • Above 6 Months

Dog Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Veterinary Hospitals & Clinics
  • Pet Owners
  • Others

Dog Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Dog Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dog vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dog vaccine companies profiled in this report include-

  • Bayer
  • Vetquinol
  • Boehringer Ingelhiem
  • Ceva
  • Eli Lilly
  • Heska
  • Merck

Dog Vaccine Market Insights

Lucintel forecasts that attenuated live will remain the largest segment due to increasing infectious diseases among the dogs and it is more convenient and effective vaccines as compared to others.

Within this market, veterinary hospital & clinic is expected to witness higher growth over the forecast period.

North America will remain the largest region due to strict government regulations regarding vaccination in protecting the dogs from serious diseases as well as protect human life from dog biting.

Features of the Global Dog Vaccine Market

Market Size Estimates: Dog vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Dog vaccine market size by type, age, end use, and region in terms of value ($B).

Regional Analysis: Dog vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, ages, end uses, and regions for the dog vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dog vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the dog vaccine market size?

Answer: The global dog vaccine market is expected to reach an estimated $4.6 billion by 2030.

Q.2 What is the growth forecast for dog vaccine market?

Answer: The global dog vaccine market is expected to grow with a CAGR of 5.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the dog vaccine market?

Answer: The major drivers for this market are increasing adoption of pet dogs, pet owners are becoming more aware of the benefits of preventive healthcare for their dogs, and government regulations for vaccinations.

Q4. What are the major segments for dog vaccine market?

Answer: The future of the dog vaccine market looks promising with opportunities in the veterinary hospital & clinic and pet owner markets.

Q5. Who are the key dog vaccine market companies?

Answer: Some of the key dog vaccine companies are as follows:

  • Bayer
  • Vetquinol
  • Boehringer Ingelhiem
  • Ceva
  • Eli Lilly
  • Heska
  • Merck

Q6. Which dog vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that attenuated live will remain the largest segment due to increasing infectious diseases among the dogs and it is more convenient and effective vaccines as compared to others.

Q7. In dog vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to strict government regulations regarding vaccination in protecting the dogs from serious diseases as well as protect human life from dog biting.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the dog vaccine market by type (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, dna vaccines, and recombinant vaccine), age (below 6 months and above 6 months), end use (veterinary hospitals & clinics, pet owners, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Dog Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Dog Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Dog Vaccine Market by Type
    • 3.3.1: Attenuated Live Vaccines
    • 3.3.2: Conjugate Vaccines
    • 3.3.3: Inactivated Vaccines
    • 3.3.4: Subunit Vaccines
    • 3.3.5: Toxoid Vaccines
    • 3.3.6: DNA Vaccines
    • 3.3.7: Recombinant Vaccine
  • 3.4: Global Dog Vaccine Market by Age
    • 3.4.1: Below 6 months
    • 3.4.2: Above 6 months
  • 3.5: Global Dog Vaccine Market by End Use
    • 3.5.1: Veterinary Hospitals & Clinics
    • 3.5.2: Pet Owners
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Dog Vaccine Market by Region
  • 4.2: North American Dog Vaccine Market
    • 4.2.2: North American Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
  • 4.3: European Dog Vaccine Market
    • 4.3.1: European Dog Vaccine Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
    • 4.3.2: European Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
  • 4.4: APAC Dog Vaccine Market
    • 4.4.1: APAC Dog Vaccine Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
    • 4.4.2: APAC Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
  • 4.5: ROW Dog Vaccine Market
    • 4.5.1: ROW Dog Vaccine Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
    • 4.5.2: ROW Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Dog Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Dog Vaccine Market by Age
    • 6.1.3: Growth Opportunities for the Global Dog Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Dog Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Dog Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Dog Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dog Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bayer
  • 7.2: Vetquinol
  • 7.3: Boehringer Ingelhiem
  • 7.4: Ceva
  • 7.5: Eli Lilly
  • 7.6: Heska
  • 7.7: Merck